Quantcast

Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet


Shutterstock photo

Midway through trading Friday, the Dow traded down 0.83 percent to 24,965.44 while the NASDAQ declined 0.35 percent to 7,733.67. The S&P also fell, dropping 0.39 percent to 2,771.44.

Leading and Lagging Sectors

On Friday, the real estate shares surged 0.64 percent. Meanwhile, top gainers in the sector included Transcontinental Realty Investors, Inc. (NYSE: TCI ) up 11 percent, and Urstadt Biddle Properties Inc. (NYSE: UBP ) up 6 percent.

In trading on Friday, energy shares fell 1.71 percent.

Top Headline

Adobe Systems Incorporated (NASDAQ: ADBE ) reported better-than-expected earnings for its second quarter on Thursday. The company issued strong third quarter earnings and sales guidance.

Earnings came in at $1.66, beating estimates by 12 cents. Sales came in at $2.195 billion, beating estimates by $35 million.

Equities Trading UP

Avalara, Inc. (NYSE: AVLR ) shares shot up 55 percent to $37.21. Avalara priced its IPO at $24 per share.

Shares of Canada Goose Holdings Inc. (NYSE: GOOS ) got a boost, shooting up 28 percent to $58.74 following Q4 results. Canada Goose posted Q4 earnings of $0.09 per share on sales of $124.821 million.

Verrica Pharmaceuticals Inc.. (NASDAQ: VRCA ) shares were also up, gaining 22 percent to $18.35. Verrica Pharma priced its IPO at $15 per share.

Equities Trading DOWN

Achieve Life Sciences, Inc. (NASDAQ: ACHV ) shares dropped 30 percent to $3.62 after reporting pricing of $12 million underwritten public offering.

Shares of Affimed N.V. (NASDAQ: AFMD ) were down 17 percent to $2.025 after the release of updated data on its Hodgkin lymphoma treatment candidate. Affimed made a poster presentation at the European Hematology Association Congress of new interim data from a Phase 1b dose escalation study that evaluated AFM13, its lead NK cell engager candidate, in combination with Merck & Co., Inc. (NYSE: MRK )'s Keytruda for relapsed/refractory Hodgkin lymphoma.

Global Blood Therapeutics, Inc. (NASDAQ: GBT ) was down, falling around 14 percent to $40.50 after announcing new Phase 2a voxelotor data in adolescents with sickle cell disease at the EHA 2018.

Commodities

In commodity news, oil traded down 2.74 percent to $65.06 while gold traded down 1.93 percent to $1,283.00.

Silver traded down 3.52 percent Friday to $16.655, while copper fell 2.42 to $3.144.

Eurozone

European shares were lower today. The eurozone's STOXX 600 dropped 0.72 percent, the Spanish Ibex Index fell 0.84 percent, while Italy's FTSE MIB Index dipped 0.88 percent. Meanwhile the German DAX dropped 0.51 percent, and the French CAC 40 fell 0.16 percent while U.K. shares fell 1.31 percent.

Economics

The Empire State manufacturing index increased 4.9 points to a reading of 25 in June. However, economists were expecting a reading of 19.

U.S. industrial production declined 0.1 percent for May, versus economists' expectations for a 0.2 percent rise.

The University of Michigan's consumer sentiment index rose to 99.30 in June, versus prior reading of 98.00. Economists expected a reading of 98.50.

The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Dallas Federal Reserve Bank President Robert Kaplan is set to speak at 1:30 p.m. ET.

The Treasury International Capital report for April is schedule for release at 4:00 p.m. ET.

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Profit with More New & Research . Gain access to a streaming platform with all the information you need to invest better today. Click here to start your 14 Day Trial of Benzinga Professional

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Commodities
Referenced Symbols: ADBE , MRK , TCI , UBP , AFMD




More from Benzinga

Subscribe






Contributor:

Benzinga

Market Analysis, FinTech












Research Brokers before you trade

Want to trade FX?